SKYEPHARMA

Serial Number 87730607
Registration 5742573
780

Registration Progress

Application Filed
Dec 21, 2017
Under Examination
Jan 15, 2019
Approved for Publication
Nov 20, 2018
Published for Opposition
Nov 20, 2018
Registered
May 7, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-05-07) (Grace Period Filing)
Due: Nov 07, 2025 Grace Period - 12 days
Original deadline was May 07, 2025 (overdue)

Trademark Image

SKYEPHARMA

Basic Information

Serial Number
87730607
Registration Number
5742573
Filing Date
December 21, 2017
Registration Date
May 7, 2019
Published for Opposition
November 20, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
780
Status Date
Jan 3, 2022
Registration
Registered
Classes
042

Rights Holder

Jagotec AG

03
Address
Eptingerstrasse 61
Muttenz 4132
CH

Ownership History

Jagotec AG

Original Applicant
03
Muttenz CH

Jagotec AG

Owner at Publication
03
Muttenz CH

Jagotec AG

Original Registrant
03
Muttenz CH

Legal Representation

Attorney
ROBERTA S BREN

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-05-07)
Due Date
May 07, 2025
Grace Period Ends
November 07, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
May 7, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 3, 2022 TMBN T TTAB RELEASE CASE TO TRADEMARKS Loading...
Jan 3, 2022 CANT T CANCELLATION TERMINATED NO. 999999 Loading...
Dec 24, 2021 A7OK O AMENDMENT UNDER SECTION 7 - PROCESSED Loading...
Dec 20, 2021 CAND T CANCELLATION DENIED NO. 999999 Loading...
Nov 30, 2021 PETC T CANCELLATION INSTITUTED NO. 999999 Loading...
May 7, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 2, 2019 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Apr 2, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 15, 2019 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Mar 15, 2019 D1BR I TEAS DELETE 1(B) BASIS RECEIVED Loading...
Jan 15, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 20, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 20, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 31, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 10, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 10, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 10, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 10, 2018 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 10, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 3, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 2, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 2, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 5, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 2, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 10, 2018 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jan 9, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 25, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical research and development in the fields of pharmaceutical delivery methods and the development of new pharmaceuticals; research and development of new surgical products for others; veterinary research and development; scientific research and development; new product design services for others; product development; engineering design services for others

Additional Information

Design Mark
The mark consists of the word "SKYEPHARMA" and a shaded circle design with parallel lines forming a circle shape, all positioned to the left of the wording. One line extends from the design under the wording.
Color Claim
Color is not claimed as a feature of the mark.
Other
In the Statement, class 5, is updated per the Board Order dated 12-20-2021.
Pseudo Mark
SKYE PHARMA

Classification

International Classes
042